Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 87

1.

Progress Toward Regional Measles Elimination - Worldwide, 2000-2015.

Patel MK, Gacic-Dobo M, Strebel PM, Dabbagh A, Mulders MN, Okwo-Bele JM, Dumolard L, Rota PA, Kretsinger K, Goodson JL.

MMWR Morb Mortal Wkly Rep. 2016 Nov 11;65(44):1228-1233. doi: 10.15585/mmwr.mm6544a6.

2.

Real-Time Monitoring of Vaccination Campaign Performance Using Mobile Phones - Nepal, 2016.

Oh DH, Dabbagh A, Goodson JL, Strebel PM, Thapa S, Giri JN, Shakya SR, Khanal S.

MMWR Morb Mortal Wkly Rep. 2016 Oct 7;65(39):1072-1076. doi: 10.15585/mmwr.mm6539a5.

3.

Global Measles and Rubella Laboratory Network Support for Elimination Goals, 2010-2015.

Mulders MN, Rota PA, Icenogle JP, Brown KE, Takeda M, Rey GJ, Ben Mamou MC, Dosseh AR, Byabamazima CR, Ahmed HJ, Pattamadilok S, Zhang Y, Gacic-Dobo M, Strebel PM, Goodson JL.

MMWR Morb Mortal Wkly Rep. 2016 May 6;65(17):438-42. doi: 10.15585/mmwr.mm6517a3.

4.

Using Seroprevalence and Immunisation Coverage Data to Estimate the Global Burden of Congenital Rubella Syndrome, 1996-2010: A Systematic Review.

Vynnycky E, Adams EJ, Cutts FT, Reef SE, Navar AM, Simons E, Yoshida LM, Brown DW, Jackson C, Strebel PM, Dabbagh AJ.

PLoS One. 2016 Mar 10;11(3):e0149160. doi: 10.1371/journal.pone.0149160. eCollection 2016. Review.

5.

Progress toward regional measles elimination - worldwide, 2000-2014.

Perry RT, Murray JS, Gacic-Dobo M, Dabbagh A, Mulders MN, Strebel PM, Okwo-Bele JM, Rota PA, Goodson JL.

MMWR Morb Mortal Wkly Rep. 2015 Nov 13;64(44):1246-51. doi: 10.15585/mmwr.6444a4.

6.

Global Progress Toward Rubella and Congenital Rubella Syndrome Control and Elimination - 2000-2014.

Grant GB, Reef SE, Dabbagh A, Gacic-Dobo M, Strebel PM.

MMWR Morb Mortal Wkly Rep. 2015 Sep 25;64(37):1052-5. doi: 10.15585/mmwr.mm6437a5.

7.

Development of a District-Level Programmatic Assessment Tool for Risk of Measles Virus Transmission.

Lam E, Schluter WW, Masresha BG, Teleb N, Bravo-Alcántara P, Shefer A, Jankovic D, McFarland J, Elfakki E, Takashima Y, Perry RT, Dabbagh AJ, Banerjee K, Strebel PM, Goodson JL.

Risk Anal. 2017 Jun;37(6):1052-1062. doi: 10.1111/risa.12409. Epub 2015 May 15.

PMID:
25976980
8.

Measles vaccine still saves children's lives.

Durrheim DN, Strebel PM.

Lancet. 2015 Jan 24;385(9965):327. doi: 10.1016/S0140-6736(15)60114-3. No abstract available.

PMID:
25706848
9.

Measles - The epidemiology of elimination.

Durrheim DN, Crowcroft NS, Strebel PM.

Vaccine. 2014 Dec 5;32(51):6880-6883. doi: 10.1016/j.vaccine.2014.10.061. Epub 2014 Nov 4. Review.

10.

Progress toward regional measles elimination--worldwide, 2000-2013.

Perry RT, Gacic-Dobo M, Dabbagh A, Mulders MN, Strebel PM, Okwo-Bele JM, Rota PA, Goodson JL; Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2014 Nov 14;63(45):1034-8.

11.

Global control and regional elimination of measles, 2000-2012.

Perry RT, Gacic-Dobo M, Dabbagh A, Mulders MN, Strebel PM, Okwo-Bele JM, Rota PA, Goodson JL; Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2014 Feb 7;63(5):103-7.

12.

Think globally, act locally: the role of local demographics and vaccination coverage in the dynamic response of measles infection to control.

Ferrari MJ, Grenfell BT, Strebel PM.

Philos Trans R Soc Lond B Biol Sci. 2013 Jun 24;368(1623):20120141. doi: 10.1098/rstb.2012.0141. Print 2013 Aug 5.

13.

The estimated mortality impact of vaccinations forecast to be administered during 2011-2020 in 73 countries supported by the GAVI Alliance.

Lee LA, Franzel L, Atwell J, Datta SD, Friberg IK, Goldie SJ, Reef SE, Schwalbe N, Simons E, Strebel PM, Sweet S, Suraratdecha C, Tam Y, Vynnycky E, Walker N, Walker DG, Hansen PM.

Vaccine. 2013 Apr 18;31 Suppl 2:B61-72. doi: 10.1016/j.vaccine.2012.11.035. Review.

PMID:
23598494
14.

Enabling implementation of the Global Vaccine Action Plan: developing investment cases to achieve targets for measles and rubella prevention.

Thompson KM, Strebel PM, Dabbagh A, Cherian T, Cochi SL.

Vaccine. 2013 Apr 18;31 Suppl 2:B149-56. doi: 10.1016/j.vaccine.2012.11.091. Review.

PMID:
23598476
15.

Reducing the global burden of congenital rubella syndrome.

Reef SE, Chu SY, Cochi SL, Kezaala R, van den Ent M, Gay A, de Quadros C, Strebel PM.

Lancet. 2012 Sep 29;380(9848):1145-6. doi: 10.1016/S0140-6736(12)61663-8. No abstract available.

PMID:
23021280
16.

Research priorities for global measles and rubella control and eradication.

Goodson JL, Chu SY, Rota PA, Moss WJ, Featherstone DA, Vijayaraghavan M, Thompson KM, Martin R, Reef S, Strebel PM.

Vaccine. 2012 Jul 6;30(32):4709-16. doi: 10.1016/j.vaccine.2012.04.058. Epub 2012 Apr 28.

17.

Etiologies of rash and fever illnesses in Campinas, Brazil.

de Moraes JC, Toscano CM, de Barros EN, Kemp B, Lievano F, Jacobson S, Afonso AM, Strebel PM, Cairns KL; VigiFex Group.

J Infect Dis. 2011 Sep 1;204 Suppl 2:S627-36. doi: 10.1093/infdis/jir490.

PMID:
21954258
18.

Global use of rubella vaccines, 1980-2009.

Strebel PM, Gacic-Dobo M, Reef S, Cochi SL.

J Infect Dis. 2011 Sep 1;204 Suppl 2:S579-84. doi: 10.1093/infdis/jir447.

PMID:
21954250
19.

Comparing measles with previous eradication programs: enabling and constraining factors.

Keegan R, Dabbagh A, Strebel PM, Cochi SL.

J Infect Dis. 2011 Jul;204 Suppl 1:S54-61. doi: 10.1093/infdis/jir119. Review.

PMID:
21666211
20.

A world without measles.

Strebel PM, Cochi SL, Hoekstra E, Rota PA, Featherstone D, Bellini WJ, Katz SL.

J Infect Dis. 2011 Jul;204 Suppl 1:S1-3. doi: 10.1093/infdis/jir111. No abstract available.

PMID:
21666150
21.

Community-level incentives to increase the use of vaccination services in developing countries: an idea whose time has come?

Behl AS, Vijayaraghavan M, Nordin JD, Maciosek MV, Strebel PM.

Vaccine. 2010 Aug 31;28(38):6123-4. doi: 10.1016/j.vaccine.2010.06.115. Epub 2010 Jul 15. No abstract available.

PMID:
20637772
22.

Laboratory confirmation of measles in elimination settings: experience from the Republic of the Marshall Islands, 2003.

Hyde TB, Nandy R, Hickman CJ, Langidrik JR, Strebel PM, Papania MJ, Seward JF, Bellini WJ.

Bull World Health Organ. 2009 Feb;87(2):93-8.

23.

Estimates of measles case fatality ratios: a comprehensive review of community-based studies.

Wolfson LJ, Grais RF, Luquero FJ, Birmingham ME, Strebel PM.

Int J Epidemiol. 2009 Feb;38(1):192-205. doi: 10.1093/ije/dyn224. Review.

PMID:
19188207
24.

Building an immunity fence against measles.

Orenstein WA, Strebel PM, Hinman AR.

J Infect Dis. 2007 Nov 15;196(10):1433-5. Epub 2007 Oct 31. No abstract available.

PMID:
18008219
25.

Utility of composite reference standards and latent class analysis in evaluating the clinical accuracy of diagnostic tests for pertussis.

Baughman AL, Bisgard KM, Cortese MM, Thompson WW, Sanden GN, Strebel PM.

Clin Vaccine Immunol. 2008 Jan;15(1):106-14. Epub 2007 Nov 7.

26.

Has the 2005 measles mortality reduction goal been achieved? A natural history modelling study.

Wolfson LJ, Strebel PM, Gacic-Dobo M, Hoekstra EJ, McFarland JW, Hersh BS; Measles Initiative.

Lancet. 2007 Jan 20;369(9557):191-200.

PMID:
17240285
27.

Measles surveillance: the importance of finding the tip of the iceberg.

Papania MJ, Strebel PM.

Lancet. 2005 Jan 8-14;365(9454):100-1. No abstract available.

PMID:
15639275
28.

Vaccine policy changes and epidemiology of poliomyelitis in the United States.

Alexander LN, Seward JF, Santibanez TA, Pallansch MA, Kew OM, Prevots DR, Strebel PM, Cono J, Wharton M, Orenstein WA, Sutter RW.

JAMA. 2004 Oct 13;292(14):1696-701.

PMID:
15479934
29.

Measles vaccines and the potential for worldwide eradication of measles.

Meissner HC, Strebel PM, Orenstein WA.

Pediatrics. 2004 Oct;114(4):1065-9.

PMID:
15466106
30.

Development of a rubella vaccination strategy: contribution of a rubella susceptibility study of women of childbearing age in Kyrgyzstan, 2001.

Malakmadze N, Zimmerman LA, Uzicanin A, Shteinke L, Caceres VM, Kasymbekova K, Sozina I, Glasser JW, Joldubaeva M, Aidyralieva C, Icenogle JP, Strebel PM, Reef SE.

Clin Infect Dis. 2004 Jun 15;38(12):1780-3. Epub 2004 May 17.

PMID:
15227627
31.

Global measles elimination efforts: the significance of measles elimination in the United States.

Strebel PM, Henao-Restrepo AM, Hoekstra E, Olive JM, Papania MJ, Cochi SL.

J Infect Dis. 2004 May 1;189 Suppl 1:S251-7.

PMID:
15106119
32.

Waving goodbye to measles.

Strebel PM, Cochi SL.

Nature. 2001 Dec 13;414(6865):695-6. No abstract available.

PMID:
11742373
33.

Molecular epidemiology of Bordetella pertussis by pulsed-field gel electrophoresis profile: Cincinnati, 1989-1996.

Bisgard KM, Christie CD, Reising SF, Sanden GN, Cassiday PK, Gomersall C, Wattigney WA, Roberts NE, Strebel PM.

J Infect Dis. 2001 May 1;183(9):1360-7. Epub 2001 Mar 23.

PMID:
11294667
34.

Measles eradication: is it in our future?

Orenstein WA, Strebel PM, Papania M, Sutter RW, Bellini WJ, Cochi SL.

Am J Public Health. 2000 Oct;90(10):1521-5.

35.

Economic evaluation of use of diphtheria, tetanus, and acellular pertussis vaccine or diphtheria, tetanus, and whole-cell pertussis vaccine in the United States, 1997.

Ekwueme DU, Strebel PM, Hadler SC, Meltzer MI, Allen JW, Livengood JR.

Arch Pediatr Adolesc Med. 2000 Aug;154(8):797-803.

PMID:
10922276
36.

Factors determining prevalence of maternal antibody to measles virus throughout infancy: a review.

Cáceres VM, Strebel PM, Sutter RW.

Clin Infect Dis. 2000 Jul;31(1):110-9. Epub 2000 Jul 25. Review.

PMID:
10913406
37.

Epidemic diphtheria in the Republic of Georgia, 1993-1996: risk factors for fatal outcome among hospitalized patients.

Quick ML, Sutter RW, Kobaidze K, Malakmadze N, Strebel PM, Nakashidze R, Murvanidze S.

J Infect Dis. 2000 Feb;181 Suppl 1:S130-7.

PMID:
10657204
38.

Risk factors for diphtheria: a prospective case-control study in the Republic of Georgia, 1995-1996.

Quick ML, Sutter RW, Kobaidze K, Malakmadze N, Nakashidze R, Murvanidze S, Wooten KG, Strebel PM.

J Infect Dis. 2000 Feb;181 Suppl 1:S121-9.

PMID:
10657203
39.

Clinical characteristics and management of 676 hospitalized diphtheria cases, Kyrgyz Republic, 1995.

Kadirova R, Kartoglu HU, Strebel PM.

J Infect Dis. 2000 Feb;181 Suppl 1:S110-5.

PMID:
10657201
40.

Epidemic diphtheria in the Kyrgyz Republic, 1994-1998.

Glinyenko VM, Abdikarimov ST, Firsova SN, Sagamonjan EA, Kadirova R, Nuorti JP, Strebel PM.

J Infect Dis. 2000 Feb;181 Suppl 1:S98-S103.

PMID:
10657199
41.

Measles epidemic in Romania, 1996-1998: assessment of vaccine effectiveness by case-control and cohort studies.

Hennessey KA, Ion-Nedelcu N, Craciun MD, Toma F, Wattigney W, Strebel PM.

Am J Epidemiol. 1999 Dec 1;150(11):1250-7.

PMID:
10588086
42.

Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990-1996.

Güriş D, Strebel PM, Bardenheier B, Brennan M, Tachdjian R, Finch E, Wharton M, Livengood JR.

Clin Infect Dis. 1999 Jun;28(6):1230-7.

PMID:
10451158
43.

Epidemiology of epidemic diphtheria in three regions, Russia, 1994-1996.

Vitek CR, Brisgalov SP, Bragina VY, Zhilyakov AM, Bisgard KM, Brennan M, Kravtsova ON, Lushniak BD, Lyerla R, Markina SS, Strebel PM.

Eur J Epidemiol. 1999 Jan;15(1):75-83.

PMID:
10098999
44.

Measles.

Strebel PM.

Bull World Health Organ. 1998;76 Suppl 2:154-5. No abstract available.

45.

Risk of diphtheria among schoolchildren in the Russian Federation in relation to time since last vaccination.

Vitek CR, Brennan MB, Gotway CA, Bragina VY, Govorukina NV, Kravtsova ON, Rhodes PH, Bisgard KM, Strebel PM.

Lancet. 1999 Jan 30;353(9150):355-8.

PMID:
9950440
46.

Haemophilus influenzae invasive disease in the United States, 1994-1995: near disappearance of a vaccine-preventable childhood disease.

Bisgard KM, Kao A, Leake J, Strebel PM, Perkins BA, Wharton M.

Emerg Infect Dis. 1998 Apr-Jun;4(2):229-37.

47.

Respiratory diphtheria in the United States, 1980 through 1995.

Bisgard KM, Hardy IR, Popovic T, Strebel PM, Wharton M, Chen RT, Hadler SC.

Am J Public Health. 1998 May;88(5):787-91. Review.

48.

Underreporting of pertussis deaths in the United States: need for improved surveillance.

Shaikh R, Guris D, Strebel PM, Wharton M.

Pediatrics. 1998 Feb;101(2):323. No abstract available.

PMID:
9457164
49.

Postlicensure effectiveness of varicella vaccine during an outbreak in a child care center.

Izurieta HS, Strebel PM, Blake PA.

JAMA. 1997 Nov 12;278(18):1495-9.

PMID:
9363968
50.

Effectiveness of the pertussis vaccination program as determined by use of the screening method: United States, 1992-1994.

Guris D, Strebel PM, Tachdjian R, Bardenheier B, Wharton M, Hadler SC.

J Infect Dis. 1997 Aug;176(2):456-63.

PMID:
9237712

Supplemental Content

Loading ...
Support Center